|
Teruel R, Martínez-Martínez I, Guerrero JA, González-Conejero R, de la Morena-Barrio ME, Salloum-Asfar S, Arroyo AB, Águila S, García-Barberá N, Miñano A, Vicente V, Corral J, Martínez C. Control of post-translational modifications in antithrombin during murine post-natal development by miR-200a. J Biomed Sci. 2013 May 16;20:29. doi: 10.1186/1423-0127-20-29. PubMed PMID: 23678987; PubMed Central PMCID: PMC3674942.
AÑO: 2013; IF: 2.736
|
23678987
|
Pérez-Andreu V, Teruel R, Corral J, Roldán V, García-Barberá N, Salloum-Asfar S, Gómez-Lechón MJ, Bourgeois S, Deloukas P, Wadelius M, Vicente V, González-Conejero R, Martínez C. miR-133a regulates vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1), a key protein in the vitamin K cycle. Mol Med. 2013 Jan 22;18:1466-72. doi: 10.2119/molmed.2012.00062. PubMed PMID: 23154637; PubMed Central PMCID: PMC3563709.
AÑO: 2012; IF: 4.469
|
|
Corral J, Lozano ML, González-Conejero R, Martínez C, Iniesta JA, Rivera J, Vicente V. A common polymorphism flanking the ATG initiator codon of GPIb alpha does not affect expression and is not a major risk factor for arterial thrombosis. Thromb Haemost. 2000 Jan;83(1):23-8. PubMed PMID: 10669149.
AÑO: 2000; IF: 4.357
|
|
Corral J, González-Conejero R, Iniesta JA, Rivera J, Martínez C, Vicente V. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica. 2000 Mar;85(3):293-7. PubMed PMID: 10702819.
AÑO: 2000; IF: 3.226
|
|
González-Conejero R, Lozano ML, Corral J, Martínez C, Vicente V. The TFPI 536C-->T mutation is not associated with increased risk for venous or arterial thrombosis. Thromb Haemost. 2000 May;83(5):787-8. PubMed PMID: 10823280.
AÑO: 2000; IF: 4.357
|